Search results
Results From The WOW.Com Content Network
Seagen Inc. (formerly Seattle Genetics, Inc.) is an American biotechnology company focused on developing and commercializing innovative, empowered monoclonal antibody -based therapies for the treatment of cancer. The company, headquartered in Bothell, Washington (a suburb of Seattle ), is the industry leader in antibody-drug conjugates or ADCs ...
The following table lists the largest biotechnology and pharmaceutical companies ranked by market capitalization in billion US dollars. The change column indicates the company's relative position in this list compared to their relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.
After the close of trading on October 18, 2021, CMO ceased to be publicly traded on the New York Stock Exchange. At the open of trading on October 19, 2021, the combined company will trade on the NYSE under the ticker symbol FBRT. October 11, 2021: CCSI: Consensus Cloud Solutions: RGS: Regis Corporation
It has been a very good year for Seattle Genetics and its investors. Sales of Adcetris posted solid results in its first full year on the market, and high-profile collaborations with AbbVie and ...
Shares of Seattle Genetics (NAS: SGEN) hit a 52-week high on Friday. Skip to main content. Sign in. Mail. 24/7 Help. For premium support please call: 800-290-4726 more ways to ...
For premium support please call: 800-290-4726 more ways to reach us
This was a pivotal year for Seattle Genetics (NAS: SGEN) ; a biotech getting its first drug approved is always a pivotal event, even when it's widely anticipated. Expect more of the same in 2012.
Nasdaq-100. The Nasdaq-100 ( ^NDX [2]) is a stock market index made up of equity securities issued by 100 of the largest non-financial companies listed on the Nasdaq stock exchange. It is a modified capitalization-weighted index. The stocks' weights in the index are based on their market capitalizations, with certain rules capping the influence ...